JDSCX
Price
$33.44
Change
-$1.41 (-4.05%)
Updated
Dec 18 closing price
VSGIX
Price
$79.22
Change
-$3.67 (-4.43%)
Updated
Dec 18 closing price
Ad is loading...

JDSCX vs VSGIX

Header iconJDSCX vs VSGIX Comparison
Open Charts JDSCX vs VSGIXBanner chart's image
JPMorgan Small Cap Blend I
Price$33.44
Change-$1.41 (-4.05%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$79.22
Change-$3.67 (-4.43%)
VolumeN/A
CapitalizationN/A
JDSCX vs VSGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDSCX vs. VSGIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDSCX is a Hold and VSGIX is a Hold.

FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 40.7B vs. JDSCX (1.66B). VSGIX pays higher dividends than JDSCX: VSGIX (0.67) vs JDSCX (0.33). JDSCX was incepted earlier than VSGIX: JDSCX (26 years) vs VSGIX (25 years). JDSCX is a more actively managed with annual turnover of: 37.00 vs. VSGIX (19.00). JDSCX has a lower initial minimum investment than VSGIX: JDSCX (1000000) vs VSGIX (5000000). JDSCX (17.40) and VSGIX (16.58) have marching annual gain over last year. VSGIX (42.32) and JDSCX (40.79) have equivalent 5 years return.
JDSCXVSGIXJDSCX / VSGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years25 years-
Gain YTD15.28316.65892%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B40.7B4%
Annual Yield % from dividends0.330.6749%
Returns for 1 year17.4016.58105%
Returns for 3 years10.053.54284%
Returns for 5 years40.7942.3296%
Returns for 10 years36.54129.6128%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGIC12.19-0.29
-2.32%
Magic Software Enterprises Ltd
HURC18.81-0.50
-2.59%
Hurco Companies
EVTC33.67-1.18
-3.39%
EVERTEC
PCOR75.75-3.68
-4.63%
Procore Technologies
LIXT1.91-0.47
-19.75%
Lixte Biotechnology Holdings